H1249
An Act relative to PANDAS/PANS screening in medical/clinical settings
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill aims to establish guidelines for screening patients for Post-Acute Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS) and Pediatric Acute Neuropsychiatric Syndrome (PANS) in medical and clinical settings. It seeks to improve the accuracy and consistency of diagnoses for these conditions, which can significantly impact a child’s development and well-being. The bill intends to standardize screening practices and promote greater awareness among healthcare providers. Currently, screening protocols vary, leading to potential delays in diagnosis and treatment.
Key provisions
- Requires medical and clinical settings to consider PANDAS/PANS screening when evaluating children with specific neurological and psychiatric symptoms.
- Encourages the development of standardized screening tools and protocols.
- Promotes education and training for healthcare professionals on PANDAS/PANS.
- Facilitates communication between patients, families, and healthcare providers regarding PANDAS/PANS.
Who is affected
- Children with neurological and psychiatric symptoms
- Parents and families of affected children
- Healthcare providers (pediatricians, neurologists, psychiatrists)
- Medical and clinical settings
Notable changes
- The bill seeks to standardize screening practices that currently lack uniformity across Massachusetts.
- It does not mandate specific screening procedures but encourages their implementation.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
James B. Eldridge
Kathleen R. LaNatra
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Bill H.1249 194th (Current)
An Act relative to PANDAS/PANS screening in medical/clinical settings
By Representative Lipper-Garabedian of Melrose, a petition (accompanied by bill, House, No. 1249) of Kate Lipper-Garabedian, Steven Owens and Samantha Montaño relative to PANDAS/PANS screening in medical/clinical settings. Financial Services.
View Text Print Preview Download PDF
Bill Information
Bill Information
Presenter: Kate Lipper-Garabedian
Tabs
Bill History Petitioners Committee Summary Hearing Attendance
Bill History
Displaying 4 actions for Bill H.1249
| Date | Branch | Action |
| 2/27/2025 | House | Referred to the committee on Financial Services |
| 2/27/2025 | Senate | Senate concurred |
| 10/15/2025 | Joint | Hearing scheduled for 10/27/2025 from 10:30 AM-04:00 PM in Gardner Auditorium |
| 2/5/2026 | House | Accompanied a new draft, see H5040 |
Similar Bills
S.805 194th (Current)
An Act relative to PANDAS/PANS screening in medical/clinical settings
H.5040 194th (Current)
An Act relative to PANDAS/PANS screening in medical/clinical settings
H.3920 193rd (2023 - 2024)
An Act relative to PANDAS/PANS screening in medical/clinical settings
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.